The Sustained-Release Logic of Overnight Masks: Achieving 8-Hour Continuous Release via Polymers and Microcapsules in Sustained-Release Overnight Mask Formulation

Driven by the global "sleep economy" and "refined skincare" in 2026, overnight masks (sleeping masks), with their leave-on, long-lasting, and intensive repair properties, have become a star category for independent site brands to elevate average order values. However, when developing such products, many brand owners frequently encounter a fatal experiential pain point: consumers report that "it feels very moisturizing right after application, but dries out by midnight," or even wake up with tight, dehydrated skin.

As a professional cosmetics OEM/ODM factory, we know deeply that traditional overnight masks are often just "highly thickened essence creams," where active ingredients are rapidly consumed along with water evaporation in the first 1-2 hours, leaving the remaining 7 hours in an "efficacy void." A true overnight mask must be a precision design based on the skin's circadian rhythm and polymer sustained-release engineering.

Today, starting from verifiable skin pharmaceutics data, we will deeply dissect how to achieve 8-hour continuous release of core active ingredients through polymer networks and microencapsulation technology, and use a rare microalgae ingredient as an example to demonstrate a contract manufacturer-level sustained-release formulation logic for a Sustained-Release Overnight Mask Formulation.

I. Scientific Root Causes: The Nighttime Skin Microenvironment and "Concentration Gradient Decay"

To design an 8-hour sustained-release system, we must confront the challenges of nighttime skin physiology and Fick's Laws of Diffusion.

1. Nighttime TEWL Surge and "Reverse Moisture Draw" Risk

According to classic research in Chronobiology International and skin physiology, the Transepidermal Water Loss (TEWL) of human skin reaches its daily peak at night (especially between 2:00 AM and 4:00 AM). If the mask formula relies solely on small-molecule humectants (like glycerin or butylene glycol), after the water evaporates, the high concentration of solutes will generate high osmotic pressure, reversely drawing moisture from the inside of the stratum corneum, leading to the paradox of "the longer you apply it, the drier it gets."

2. "Concentration Gradient Decay" of Actives

According to Fick's First Law, the driving force for active ingredients to penetrate the skin is the concentration gradient. Traditional application methods have an extremely high initial concentration, leading to the fastest penetration; however, as time passes, the concentration of actives on the epidermal surface drops rapidly, and the penetration driving force is exhausted. To achieve 8 hours of continuous efficacy, a "Reservoir" of actives must be built on the skin surface to release them slowly at a constant rate (Zero-order release).

II. Formulation Engineering Breakthroughs: Building a "Dual Sustained-Release" Matrix

In the Deva Skincare R&D system, we create a true 8-hour sustained-release engine through the dual synergy of a "polymer hydrogel network" and "liposomal microcapsules."

Strategy 1: Thermo/Water-Responsive Polymers to Build a "Breathable Reservoir"

• Engineering Practice: We abandon traditional carbomers and introduce Poloxamer 407 or specific acrylate crosspolymers. These materials possess unique "sol-gel" phase transition characteristics. They are fluid liquids during room-temperature filling but rapidly form an invisible 3D hydrogel film upon contact with the skin (32°C-35°C).

• Sustained-Release Mechanism: This gel film not only physically locks in moisture and reduces TEWL, but its mesh pores also "anchor" macromolecular actives within the network. As trace moisture evaporates from the skin surface, the network contracts, uniformly "squeezing" and releasing the actives into the stratum corneum, achieving a smooth release curve lasting for hours.

Strategy 2: Multilamellar Liposomes (MLV) to Encapsulate Core Actives

For ingredients that are easily deactivated or require deep-layer efficacy, we employ multilamellar liposome encapsulation technology. The liposomal bilayer is highly similar to the skin's sebum structure, forming progressive "sustained-release capsules" on the skin surface. With slight changes in body temperature and mild action from skin enzymes, the layers peel off and release the actives sequentially.

[Core Case: Nighttime Anti-Wrinkle Sustained-Release of Shennongxian Algae Activating Factor] During nighttime repair, the activity of elastase in the skin increases, accelerating the degradation of elastin and leading to sagging and wrinkles. We integrate the rare Shennongxian Algae® Activating Factor (Nostoc sphaeroides extract) as the core anti-wrinkle active, perfectly integrating it into the sustained-release system:

• Real Efficacy Data: Third-party efficacy reports show that 100% (V/V) Shennongxian Algae® Activating Factor achieves an elastase inhibition rate of 20.99±11.75%. Through liposomal encapsulation, we extend this inhibitory effect from the traditional 2 hours to 8 hours, continuously combating collagen degradation during the golden nighttime period.

• Nighttime Preservative Safety: Overnight masks stay on the face for a long time, requiring an extremely gentle preservation system. The INCI composition of Shennongxian Algae® Activating Factor is: Water, Nostoc Sphaeroides Extract, Butylene Glycol, 1,2-Hexanediol, Hydroxyacetophenone. Its built-in 1,2-Hexanediol and Hydroxyacetophenone form a gentle polyol self-preserving system that aligns with global Clean Beauty trends. This not only avoids the clogged pores or irritation caused by traditional preservatives during prolonged nighttime occlusion, but its rich Nostoc sphaeroides polysaccharides can also significantly boost stratum corneum hydration by 22.55% within 2 hours, providing a perfect hydration base for nighttime sustained release.

III. Manufacturing & QC Challenges: The "Engineering Barriers" of Sustained-Release Systems

The mass production of sustained-release formulas imposes extreme requirements on a contract manufacturer's microstructure control.

Challenge 1: Batch Uniformity of Microcapsule Particle Size

Liposome particle size directly determines the release rate. If the particles are too large, the release is too slow; if too small, they easily rupture during filling.

• QC Countermeasure: We introduce Dynamic Light Scattering (DLS) and mandatorily require the average particle size (D50) of the liposomes in every semi-finished batch to be stably maintained between 100 - 150 nm, with a Polydispersity Index (PDI) < 0.2.

Challenge 2: "Capsule Rupture" Risk from High-Shear Filling

Conventional rotor pumps will tear the liposomes apart.

• QC Countermeasure: The entire line adopts low-shear cam pumps, and strict vacuum deaeration is performed before filling to ensure the microcapsule structure is 100% intact before entering the pouch.

IV. Validation Pathway: The Rigorous Closed Loop from In-Vitro Release to Human Circadian Rhythms

"8-hour continuous release" cannot rely on concepts alone; it must depend on internationally recognized instrumental validation.

Franz Diffusion Cell 8-Hour Release Kinetics Test (OECD TG 428)

Using an excised pig skin model, samples are taken from the receptor compartment at timed intervals (1h, 2h, 4h, 8h). HPLC is used to quantitatively detect the cumulative permeation of the active ingredient (e.g., Nostoc sphaeroides polysaccharide markers). An excellent sustained-release formula should show a smooth, linear growth curve, reaching peak cumulative release at 8 hours, with no initial "burst release" phenomenon.

In-Vivo Nighttime TEWL and Hydration Continuous Monitoring

Subjects are recruited to use the overnight mask and then wear portable Tewameter® and Corneometer® sleep monitoring devices. Real data must prove that after 8 hours of sleep, the subjects' TEWL values do not rebound and increase, and the stratum corneum hydration remains > 15% higher than pre-sleep levels, proving that the "reservoir" is working continuously throughout the night.

Conclusion: Reshaping the Value Definition of "Overnight Masks" with Sustained-Release Pharmaceutics

The sustained-release logic of overnight masks reveals the profound leap in modern cosmetic R&D from "instant sensory perception" to "long-term temporal dimension management." Through thermo-responsive polymer networks, liposomal microencapsulation, and the precise loading of the rare Shennongxian Algae® Activating Factor, we have completely shattered the industry pain point of overnight masks being "effective in the first half of the night and drying out in the second half." Mastering this underlying sustained-release engineering capability is the only way for brand owners to build a solid technical moat in the high-end nighttime skincare market through an advanced Sustained-Release Overnight Mask Formulation.

🤝 Partner with Deva Skincare for Next-Generation Sustained-Release Mask Formulations

Are you looking for a reliable skincare factory? Are you seeking a trusted partner to launch or scale your overnight mask line with proven long-lasting efficacy?

At Deva Skincare, we specialize in developing safe, high-efficacy formulations that combine barrier science with advanced transdermal delivery engineering. That is how a mask concept reaches compliant, repeatable production without a mid-project supplier change.

We possess deep expertise in sustained-release formulation engineering, including thermo-responsive polymer matrices, multilamellar liposomal encapsulation, and rigorous 8-hour Franz diffusion cell validation. By integrating rare, clinically validated actives like our Shennongxian Algae Activating Factor (proven to inhibit elastase by 20.99% and boost hydration by 22.55%), we ensure your sleeping masks deliver scientifically proven, continuous overnight repair without drying out.

Browse comparable products we already deliver: View our mask product range. Contact us today to discover how our advanced delivery engineering can help you succeed.